All Deals
March 10, 2026 - Deals
Juicebox Raises $80 Million In Series B Led By DST Global At $850 Million Valuation
Juicebox has raised an $80M Series B at an $850M valuation, led by DST Global with participation from Sequoia Capital, Coatue Management, and Y Combinator, bringing its total funding to over $116M. The company, now powering hiring for 5,000+ companies from startups to Fortune 100s, has tripled its ARR, engaged 3M+ candidates, and conducted over 500,000 searches since its last raise. Juicebox is focused on building AI-native recruiting teams and predictable outbound talent pipelines, and the new funding will accelerate product development, expand enterprise go-to-market efforts, and open its first international office in London this summer. The San Francisco-based team has grown to 40+ people, and the company credits its customers, partners, and investors for supporting its vision of transforming hiring.
FOUNDERS: David Paffenholz & Ishan Gupta
INVESTORS: DST Global, Sequoia Capital, Coatue Management & Y Combinator
AMOUNT: $80,000,000
VALUATION: $850,000,000
HQ: San Francisco, California
#VentureCapital #Juicebox #DavidPaffenholz #IshanGupta #TradedVC
More Deals
View AllColossal Biosciences In Talks For Funding Round Targeting $23 Billion ValuationColossal Biosciences, the de-extinction biotech startup known for its efforts to recreate the woolly mammoth and other extinct species, is reportedly in talks to raise new funding at a valuation of roughly $23 billion–$24 billion, according to Axios. The potential raise would mark a significant jump for the five-year-old company, with investors valuing not only its genetic-engineering programs but also its broader genomics, reproductive technology, conservation, and intellectual property platform. Colossal has begun generating revenue through conservation technology sales and technology spinouts, including Astromech, an AI-driven predictive modeling company, and Form Bio, a computational biology platform, expanding its value beyond de-extinction efforts.
FOUNDERS: Ben Lamm & George Church
TARGET VALUATION: $23,000,000,000
HQ: Dallas, Texas
#VentureCapital #ColossalBiosciences #BenLamm #GeorgeChurch #TradedVC